search

1-20 of 40

Save search

Sort by

Sort Order Select

Journal Article

Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825 Get access

PDF

Joshua D Strauss and others

Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 767–778, https://doi.org/10.1093/neuonc/noae234

Published: 16 November 2024

Supplementary data

Journal Article

Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)

PDF

Jeffrey S Wefel and others

Neuro-Oncology, Volume 23, Issue 7, July 2021, Pages 1125–1138, https://doi.org/10.1093/neuonc/noab011

Published: 30 January 2021

Supplementary data

Journal Article

A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma

PDF

Mark R Gilbert and others

Neuro-Oncology, Volume 23, Issue 3, March 2021, Pages 468–477, https://doi.org/10.1093/neuonc/noaa240

Published: 21 October 2020

Supplementary data

Journal Article

LTBK-08. TOCA 511 & TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA

PDF

Timothy Cloughesy and others

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi284, https://doi.org/10.1093/neuonc/noz219.1199

Published: 22 November 2019

Journal Article

RTHP-35. RE-IRRADIATION USING PULSED REDUCED DOSE RATE RADIATION THERAPY IN PATIENTS WITH GRADE 2 GLIOMAS

PDF

Colin Harari and others

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi217, https://doi.org/10.1093/neuonc/noz175.906

Published: 11 November 2019

Journal Article

RTHP-37. RE-IRRADIATION OF GLIOMATOSIS CEREBRI WITH WHOLE BRAIN PULSED REDUCED DOSE RATE RE-IRRADIATION

PDF

Adam Burr and others

Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi217, https://doi.org/10.1093/neuonc/noz175.908

Published: 11 November 2019

Journal Article

Survival of patients with prior anti-angiogenic therapy

PDF

Jens Eickhoff and H Ian Robins

Neuro-Oncology, Volume 20, Issue 6, June 2018, Pages 860–861, https://doi.org/10.1093/neuonc/noy039

Published: 27 March 2018

Journal Article

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813

PDF

Susan Chang and others

Neuro-Oncology, Volume 19, Issue 2, 1 February 2017, Pages 252–258, https://doi.org/10.1093/neuonc/now236

Published: 16 December 2016

Journal Article

MPTH-41. MGMT STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 0424: A PHASE II TRIAL OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY FOR HIGH RISK LOW-GRADE GLIOMAS

PDF

Erica H. Bell and others

Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi115, https://doi.org/10.1093/neuonc/now212.478

Published: 07 November 2016

Journal Article

ACTR-21. OCCURRENCE AND IMPLICATIONS OF MYELOSUPPRESSION DURING CONCURRENT THERAPY ON RTOG 0825

PDF

Elizabeth Vera and others

Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi6, https://doi.org/10.1093/neuonc/now212.020

Published: 07 November 2016

Journal Article

ATCT-12RESULTS OF NRG ONCOLOGY/RTOG 9813- A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) THERAPY FOR ANAPLASTIC ASTROCYTOMA (AA)

PDF

Susan Chang and others

Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v3, https://doi.org/10.1093/neuonc/nov206.12